Adult osteomalacia
Chapter 13:Diseases of the musculoskeletal system
ICD-10 M83 is a billable code used to indicate a diagnosis of adult osteomalacia.
Adult osteomalacia is a metabolic bone disorder characterized by the softening of bones due to inadequate mineralization, primarily caused by a deficiency of vitamin D, calcium, or phosphate. This condition leads to decreased bone density and an increased risk of fractures. In adults, osteomalacia can result from various factors, including malabsorption syndromes, chronic kidney disease, and certain medications that affect bone metabolism. Clinically, patients may present with bone pain, muscle weakness, and an increased susceptibility to fractures, particularly in weight-bearing bones. Diagnosis typically involves a combination of clinical evaluation, laboratory tests to assess vitamin D and mineral levels, and imaging studies such as X-rays or bone density scans to evaluate bone health. Treatment focuses on correcting the underlying nutritional deficiencies, often through supplementation and dietary modifications, alongside addressing any contributing medical conditions. Monitoring bone density and fracture risk is crucial in managing patients with osteomalacia to prevent complications.
Detailed history of metabolic disorders, laboratory results, and treatment plans.
Patients with vitamin D deficiency presenting with bone pain and fractures.
Ensure comprehensive documentation of metabolic panels and follow-up care.
Assessment of joint and bone health, including imaging studies.
Patients with chronic pain and suspected metabolic bone disease.
Document any autoimmune conditions that may contribute to bone health issues.
Used to assess mineral levels in patients suspected of osteomalacia.
Document the rationale for testing and results.
Endocrinologists should ensure thorough documentation of metabolic disorders.
The primary cause of adult osteomalacia is a deficiency in vitamin D, which leads to inadequate mineralization of bone. Other contributing factors may include malabsorption syndromes, chronic kidney disease, and certain medications.
